Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium

Vaccine

Volumn 19, Issue 20-22, 2001, Pages 2945-2954

  Woo, Patrick C Y ^a   Wong, Lei po ^a   Zheng, Bo jian ^a   Yuen, Kwok yung ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

DNA vaccine; Hepatitis B virus; Live attenuated Salmonella

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; HEPATITIS B VACCINE; IMMUNOGLOBULIN G; INTERLEUKIN 4; LIVE VACCINE; MEMBRANE ANTIGEN; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HEPATITIS B VIRUS; HUMORAL IMMUNITY; IMMUNE COMPLEX DISEASE; IMMUNOGENICITY; LIVER CELL; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SERUM SICKNESS; SPLEEN CELL;

ANIMALS; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; INTERFERON TYPE II; INTERLEUKIN-4; MICE; MICE, INBRED BALB C; SALMONELLA TYPHIMURIUM; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; VACCINES, ATTENUATED; VACCINES, DNA; VACCINES, SYNTHETIC;

EID: 0035815502     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00530-2     Document Type: Article

References (27)

1. Hepatitis B virus infection in Chinese families in Hong Kong
2. Genetic prediction of nonresponse to hepatitis B vaccine
3. Revaccination against hepatitis B virus of non-responding and low-responding infants immunised at birth. A parallel evaluation of rubella and tetanus vaccine
4. Long-term follow-up in a randomised controlled trial of recombinant alpha 2-interferon in Chinese patients with chronic hepatitis B infection
5. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody
6. DNA-mediated immunization to hepatitis B surface antigen: Longevity of primary response and effect of boost
7. Optimism over vaccines administered via mucosal surfaces
8. Oral somatic transgene vaccination using attenuated S. typhimurium
9. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
10. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo
11. A new microcellular cytotoxicity test based on calcein AM release
12. A one-year trial of lamivudine for chronic hepatitis B
13. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B
14. Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy
15. Clearance of hepatitis B surface antigen after bone marrow transplantation: Role of adoptive immunity transfer
16. Use of famciclovir to prevent HBV reactivation in HBsAg-positive recipients after allogeneic bone marrow transplantation
17. Specific vaccine therapy in chronic hepatitis B: Induction of T cell proliferative responses specific for envelope antigens
18. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice
19. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo
20. Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide, and heat-inactivated bacteria
21. Regulation of hepatitis B virus mRNA expression in a hepatitis B surface antigen transgenic mouse model by IFN-gamma-secreting T cells after DNA-based immunization
22. Viral clearance without destruction of infected cells during acute HBV infection
23. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice
24. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes
25. Immunoadjuvant action of plasmid DNA in liposomes
26. Clearance of persistent hepatitis B virus infection in Chinese bone marrow transplant recipients whose donors were anti-hepatitis B core- and anti-hepatitis B surface antibody-positive
27. Response to an extra dose of hepatitis B vaccine and specific antibody persistence in non-responders to primary immunization